NeOnc Technologies Holdings, Inc. (to be listed on the NASDAQ Global Market under the symbol: NTHI), a clinical-stage medical biotechnology company, today announced the appointment of Dr. Steven L.

There is broad exposure to all neurotologic procedures involving the lateral skull base, posterior and middle cranial fossae, and temporal bone. Tumor surgery (benign and malignant), cochlear ...